TOP-5 Analyst Price Targets on 17.07.25
Reading Time: 4 minutes
Amicus Therapeutics [US03152W1099] Morgan Stanley upgrades from " Equal Weight " to " Overweight " with a price target of 12 USD (87% upside potential) Morgan Stanley highlights the strong position of Amicus regarding intellectual property (patents, rights), especially ahead of a summary judgment against Aurobindo, a potential generic manufacturer. Should this judgment favor Amicus , it would strengthen the company's exclusive rights and prevent the market entry of competing products. Furthermore, experts express confidence that patients...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
